TY  - GEN
AU  - Bonaventura,Anthony
AU  - OʼConnell,Rachel L
AU  - Mapagu,Cristina
AU  - Beale,Philip J
AU  - McNally,Orla M
AU  - Mileshkin,Linda R
AU  - Grant,Peter T
AU  - Hadley,Alison M
AU  - Goh,Jeffery C H
AU  - Sjoquist,Katrin M
AU  - Martyn,Julie
AU  - DeFazio,Anna
AU  - Scurry,James
AU  - Friedlander,Michael L
TI  - Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer
SN  - 1525-1438
PY  - 2018///0201
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anastrozole
KW  - Antineoplastic Agents, Hormonal
KW  - adverse effects
KW  - Carcinoma, Ovarian Epithelial
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Immunohistochemistry
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Neoplasms, Glandular and Epithelial
KW  - Nitriles
KW  - Organoplatinum Compounds
KW  - pharmacology
KW  - Ovarian Neoplasms
KW  - Prospective Studies
KW  - Quality of Life
KW  - Receptors, Estrogen
KW  - metabolism
KW  - Receptors, Progesterone
KW  - Tissue Array Analysis
KW  - Triazoles
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1097/IGC.0000000000000978
ER  -